Keywords: cephalon/lundbeck, terminate, pd, drug, trial, biotechnology, major

Cephalon/Lundbeck terminate PD drug trial

Article | 23 May 2005

Print This

US biotechnology major Cephalon and Danish drugmaker Lundbeck AS have discontinued the Phase II/III clinical study of their drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in